Suberoylanilide Hydroxamic Acid (SAHA) Induces Apoptosis or Autophagy-associated Cell Death in Chondrosarcoma Cell Lines
Background: Since chondrosarcoma has a high resistance to conventional chemotherapy and radiotherapy, surgical resection is currently the only effective treatment. Histone deacetylase (HDAC) inhibitor exert anticancer effects, but have not been tested in chondrosarcoma. Materials and Methods: We inv...
Gespeichert in:
Veröffentlicht in: | Anticancer research 2008-05, Vol.28 (3A), p.1585-1591 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Since chondrosarcoma has a high resistance to conventional chemotherapy and radiotherapy, surgical resection is
currently the only effective treatment. Histone deacetylase (HDAC) inhibitor exert anticancer effects, but have not been tested
in chondrosarcoma. Materials and Methods: We investigated the phenotypic change in chondrosarcoma cells treated with SAHA
by cell viability assay, Western blot, flow cytometric analysis and electron microscopy. Results: SAHA inhibited the growth
of chondrosarcoma cell lines and induced apoptosis in SW1353 with a cleaved-PARP expression and sub-G1 fragmentation according
to flow cytometric analysis. On the other hand, in RCS and OUMS-27, SAHA induced autophagy-associated cell death as shown
by the detection of autophagosome-specific protein and specific ultrastructural morphology in the cytoplasm. In addition,
SAHA significantly inhibited tumor growth in an in vivo xenograft model. Conclusion: These results suggest that SAHA might
be a promising agent for performing clinically useful chemotherapy against chondrosarcomas. |
---|---|
ISSN: | 0250-7005 1791-7530 |